TVTX — Travere Therapeutics, Inc. stock price, charts and financials

QT78Travere Therapeutics, Inc.

Travere Therapeutics, Inc. (NASDAQ: TVTX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
61.50
+0.18+0.29%
OverviewShort InterestFilings
TVTXQT78Travere Therapeutics, Inc.·NASDAQ
61.50+0.29%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 04, 20268-KCurrent report
Aug 04, 202610-QQuarterly report
Jul 09, 20268-KCurrent report
Jun 22, 20264Statement of changes in beneficial ownership
Jun 17, 2026S-8Registration of employee benefit securities
Jun 16, 20264Statement of changes in beneficial ownership
Jun 16, 20264Statement of changes in beneficial ownership
Jun 16, 20268-KCurrent report
Jun 02, 20268-KCurrent report
May 21, 20264Statement of changes in beneficial ownership
May 21, 20264Statement of changes in beneficial ownership
May 21, 20264Statement of changes in beneficial ownership
May 21, 20268-KCurrent report
May 21, 20264Statement of changes in beneficial ownership
May 21, 20264Statement of changes in beneficial ownership
May 21, 20264Statement of changes in beneficial ownership
May 21, 20264Statement of changes in beneficial ownership
May 21, 20264Statement of changes in beneficial ownership
May 21, 20264Statement of changes in beneficial ownership
May 19, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 11, 20268-KCurrent report
May 07, 2026FWPFree writing prospectus
#1 / 25 of 427
Page
▼
/ 18